AprilBio Statistics
Total Valuation
AprilBio has a market cap or net worth of KRW 518.13 billion. The enterprise value is 428.28 billion.
Market Cap | 518.13B |
Enterprise Value | 428.28B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
AprilBio has 22.53 million shares outstanding. The number of shares has decreased by -8.17% in one year.
Current Share Class | 22.53M |
Shares Outstanding | 22.53M |
Shares Change (YoY) | -8.17% |
Shares Change (QoQ) | +0.18% |
Owned by Insiders (%) | 31.10% |
Owned by Institutions (%) | 14.34% |
Float | 15.29M |
Valuation Ratios
The trailing PE ratio is 22.49 and the forward PE ratio is 61.66.
PE Ratio | 22.49 |
Forward PE | 61.66 |
PS Ratio | 17.45 |
PB Ratio | 5.61 |
P/TBV Ratio | 5.65 |
P/FCF Ratio | 23.17 |
P/OCF Ratio | 22.89 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.44, with an EV/FCF ratio of 19.15.
EV / Earnings | 18.93 |
EV / Sales | 14.43 |
EV / EBITDA | 21.44 |
EV / EBIT | 22.21 |
EV / FCF | 19.15 |
Financial Position
The company has a current ratio of 11.52, with a Debt / Equity ratio of 0.03.
Current Ratio | 11.52 |
Quick Ratio | 11.46 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.16 |
Debt / FCF | 0.14 |
Interest Coverage | 15.58 |
Financial Efficiency
Return on equity (ROE) is 30.45% and return on invested capital (ROIC) is 15.25%.
Return on Equity (ROE) | 30.45% |
Return on Assets (ROA) | 13.44% |
Return on Invested Capital (ROIC) | 15.25% |
Return on Capital Employed (ROCE) | 20.86% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.33 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.43% in the last 52 weeks. The beta is 1.51, so AprilBio's price volatility has been higher than the market average.
Beta (5Y) | 1.51 |
52-Week Price Change | +14.43% |
50-Day Moving Average | 17,488.00 |
200-Day Moving Average | 17,558.95 |
Relative Strength Index (RSI) | 81.26 |
Average Volume (20 Days) | 286,409 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AprilBio had revenue of KRW 29.69 billion and earned 22.63 billion in profits. Earnings per share was 1,022.72.
Revenue | 29.69B |
Gross Profit | 29.67B |
Operating Income | 19.28B |
Pretax Income | 22.63B |
Net Income | 22.63B |
EBITDA | 19.98B |
EBIT | 19.28B |
Earnings Per Share (EPS) | 1,022.72 |
Balance Sheet
The company has 93.07 billion in cash and 3.22 billion in debt, giving a net cash position of 89.85 billion or 3,988.58 per share.
Cash & Cash Equivalents | 93.07B |
Total Debt | 3.22B |
Net Cash | 89.85B |
Net Cash Per Share | 3,988.58 |
Equity (Book Value) | 92.33B |
Book Value Per Share | 4,106.14 |
Working Capital | 89.44B |
Cash Flow
In the last 12 months, operating cash flow was 22.64 billion and capital expenditures -271.41 million, giving a free cash flow of 22.37 billion.
Operating Cash Flow | 22.64B |
Capital Expenditures | -271.41M |
Free Cash Flow | 22.37B |
FCF Per Share | 992.83 |
Margins
Gross margin is 99.94%, with operating and profit margins of 64.94% and 76.23%.
Gross Margin | 99.94% |
Operating Margin | 64.94% |
Pretax Margin | 76.23% |
Profit Margin | 76.23% |
EBITDA Margin | 67.29% |
EBIT Margin | 64.94% |
FCF Margin | 75.34% |
Dividends & Yields
AprilBio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 8.17% |
Shareholder Yield | n/a |
Earnings Yield | 4.37% |
FCF Yield | 4.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 31, 2023. It was a forward split with a ratio of 2.
Last Split Date | Oct 31, 2023 |
Split Type | Forward |
Split Ratio | 2 |
Scores
AprilBio has an Altman Z-Score of 28.55 and a Piotroski F-Score of 5.
Altman Z-Score | 28.55 |
Piotroski F-Score | 5 |